Vera Therapeutics (VERA) Operating Expenses (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Operating Expenses came in at $125.1 million in Q1 2026, up 118.79% YoY from $57.2 million in Q1 2025, and up 32.83% on a QoQ basis from $94.2 million in Q4 2025.
Vera Therapeutics (VERA) Operating Expenses (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Operating Expenses data on file, last reported at $125.1 million in Q1 2026.
- Quarterly Operating Expenses rose 118.79% year-over-year to $125.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $383.4 million (up 98.4% YoY) and the FY2025 annual result came in at $315.5 million, up 88.71% from the prior year.
- Operating Expenses grew to $125.1 million in Q1 2026, from $94.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $125.1 million in Q1 2026 to a low of $15.1 million in Q2 2022.
- A 5-year average of $47.1 million and a median of $33.6 million in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 260.92% — and 2023, when it declined 19.51%.
- Tracing VERA's Operating Expenses over 5 years: stood at $33.6 million in 2022, then fell by 19.51% to $27.0 million in 2023, then soared by 80.98% to $48.9 million in 2024, then soared by 92.6% to $94.2 million in 2025, then jumped by 32.83% to $125.1 million in 2026.
- The last three Operating Expenses figures came in at $125.1 million (Q1 2026), $94.2 million (Q4 2025), and $83.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | 112.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.49 Mn |
| Mar 31, 2026 | 125.13 Mn |
| Dec 31, 2025 | 94.21 Mn |
| Sep 30, 2025 | 83.93 Mn |
| Jun 30, 2025 | 80.14 Mn |
| Mar 31, 2025 | 57.19 Mn |
| Dec 31, 2024 | 48.91 Mn |
| Sep 30, 2024 | 49.80 Mn |
| Jun 30, 2024 | 37.34 Mn |
| Mar 31, 2024 | 31.11 Mn |
| Dec 31, 2023 | 27.03 Mn |
| Sep 30, 2023 | 21.76 Mn |
| Jun 30, 2023 | 21.97 Mn |
| Mar 31, 2023 | 31.26 Mn |
| Dec 31, 2022 | 33.58 Mn |
| Sep 30, 2022 | 25.24 Mn |
| Jun 30, 2022 | 15.06 Mn |
| Mar 31, 2022 | 17.02 Mn |
| Dec 31, 2021 | 16.59 Mn |
| Sep 30, 2021 | 7.25 Mn |